SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0000899243-20-033765
Filing Date
2020-12-14
Accepted
2020-12-14 17:35:47
Documents
1
Period of Report
2020-12-10

Document Format Files

Seq Description Document Type Size
1 FORM 4 SUBMISSION doc4.html 4  
1 FORM 4 SUBMISSION doc4.xml 4 4182
  Complete submission text file 0000899243-20-033765.txt   5534
Mailing Address 33 HAYDEN AVENUE LEXINGTON MA 02421
Business Address 33 HAYDEN AVENUE LEXINGTON MA 02421 617 621 8097
Dicerna Pharmaceuticals Inc (Issuer) CIK: 0001399529 (see all company filings)

IRS No.: 205993609 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 2834 Pharmaceutical Preparations

Mailing Address C/O BROOKSIDE CAPITAL, LLC JOHN HANCOCK TOWER, 200 CLARENDON ST BOSTON MA 02116
Business Address
Koppel Adam (Reporting) CIK: 0001578965 (see all company filings)

Type: 4 | Act: 34 | File No.: 001-36281 | Film No.: 201387231